Prognosis For The Future, Dr. David Samadi & Robotic Prostatectomy

In 2017, 161,360 men were diagnosed with prostate cancer. The American Cancer Society estimates 164,690 cases will be confirmed this year. While these numbers are down from 172,258 in 2014 according to the Center for Disease Control and Prevention, prostate cancer is a serious issue for men aged 65 or older. The average age of diagnosis is 66. It is rare, but not impossible for prostate cancer to occur in men as early as age 40.

Doctor David Samadi, Chairman of Urology and Chief of Robotic Surgery at Lenox Hill Hospital in New York, NY suggests two possible courses of action when a prostate cancer diagnosis is confirmed. The first is surgery, such as his Robotic Assisted Laparoscopic Prostatectomy using the da Vinci system by Intuitive Surgical. While the other is radiation treatment. It is important that the patient understands the advantages and disadvantages of each method based upon their situation. The best method of treatment may differ based upon the severity or size of the cancerous tissue.

If the prostate cancer has not spread beyond the prostate gland, surgery is recommended over radiation treatments. A study by the Odette Cancer Centre by the Sunnybrook Research Institute of the University of Toronto concluded that patients with localized prostate cancer are one-and-a-half times more likely to die with radiation than with surgery. On the additional negative effects of radiation treatment of prostate cancer, Doctor Samadi states, “men who have radiation may be exposing themselves to developing a secondary cancer, such as bladder or rectal cancer due to possible side effects radiation can deliver to that area of the body.” If radiation is chosen over surgery, it is very problematic to perform surgery following the treatment if the cancer were to relapse.

Dr. Samadi urges all men with prostate cancer to learn more about their surgeons. This information includes number of successful surgeries the surgeon has performed, the rate of cancer return, continence, and sexual function post-surgery. He offers patients a near perfect survival rate in cases where cancerous tissue is localized and they opt to have their prostate removed. While radiation over surgery in a case where the cancer has spread reduces survival chances outside of five years to less than 30%.

Dr. David Samadi is a board certified urologic oncologist. He has over 7,000 successful robotic prostate surgeries with 89% of his patients remaining cancer free after robotic prostatectomy. 83% of patients regain sexual function. He has performed surgery in Germany, France, Spain, London, Israel, Greece, The Dominican Republic, and The United States. Dr. Samadi reports that his patients regain function in just one year after normal continence prior to their surgery. He seeks to further the field of robotic surgery and its adoption around the world, drastically modernizing much of the world’s view of healthcare in the coming years.

For More info: interview.net/dr-david-samadi/

This entry was posted in Cancer Research, Surgery and tagged . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *